Delivery Order SPE2DB22D3004-SPE2DB25FQD11
Award Date
4/2/25
Potential Completion Date
4/3/25
Potential Value
$1.4K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $7,093.04, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of 4567873449 - APREPITANT 40 MG CAPSULE UD 5S, and has a firm fixed price pricing type with an ultimate completion date of April 11, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp. The contract, valued at $1,105.72, is a delivery order for the pharmaceutical product APREPITANT 80 MG CAPSULE. The contract has a firm fixed price pricing type and has an ultimate completion date of January 13, 2025. This award is not associated with a set-aside program. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order valued at $7,008.15, with a Firm Fixed Price pricing type. The award is for the provision of APREPITANT 40 MG CAPSULE UD 5S, a pharmaceutical product. The contract has an Ultimate Completion Date of June 12, 2025. Amerisourcebergen Drug Corp is the prime contractor on this award, which is...
This federal contract award, valued at $4,162.95, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of APREPITANT 40 MG CAPSULE UD 5S, a pharmaceutical product, with a performance period extending through April 2025. The contract is a delivery order and is priced on a firm-fixed-price basis. It is not designated as a set-aside contract, indicating open competition....
This is a federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division, a subsidiary of Amerisourcebergen Corporation, one of the largest pharmaceutical distribution companies in the world. The contract, awarded by the Defense Logistics Agency (DLA), is for the provision of 4564445711 - APREPITANT 40 MG CAPSULE UD 5S, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price of $3,954.22 and has an ultimate completion date of May 1, 2024. This...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $12,517.22 firm-fixed-price delivery order is for the supply of 4562584778 APREPITANT 40 MG CAPSULE UD 5S, with an ultimate completion date of October 25, 2023. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., which holds a significant $999,999,999 Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $18,219.21 firm fixed-price delivery order is for APREPITANT 80 MG CAPSULE UD 6S, with a period of performance through January 15, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
This federal contract award to Amerisourcebergen Drug Corp (a subsidiary of Cencora, Inc.) is for the delivery of 4556527817 APREPITANT 80 MG CAPSULE UU 2S to the Defense Logistics Agency (DLA). The $3,531.50 firm fixed-price contract has a completion date of March 11, 2022. This delivery order was placed under Amerisourcebergen's $999,999,999 Indefinite Delivery Contract with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical supplies to...
This federal contract award, with ID SPE2DX15D1053|SPE2DX24F6PDN, was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $1,186.78 firm fixed-price Delivery Order is for the supply of 4564978529 APREPITANT 80 MG CAPSULE UD 6S. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical as the primary vehicle...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,213.68, is for the supply of 4,568,175,168 units of the medication Aprepitant 40 mg capsules. The award does not have a set-aside designation, indicating open competition. The contract has a period of performance through May 8, 2025. AmerisourceBergen also holds a larger $999,999,999.00 Indefinite Delivery...